Blueprint Medicines Corporation logo
Blueprint Medicines Corporation BPMC
report update icon

Quartalsbericht 2025-Q1
hinzugefügt 16.05.2026

Blueprint Medicines Corporation DSO | BPMC

DSO Jährlich Blueprint Medicines Corporation

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
42.5 48.6 43.5 32.7 1.78 128 - - 47 109 - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
128 1.78 56.7

DSO Vierteljährlich Blueprint Medicines Corporation

2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
47 - 53.7 47.9 48.8 - 61.3 51.6 38.6 - 13.4 35.9 39.2 - 82.8 101 88.3 - 0.87 77.6 57.4 1.17 6.62 11.8 45.4 5.65 5.33 0.07 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
101 0.07 40

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Galapagos NV Galapagos NV
GLPG
56.5 - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
178 - -4.36 % $ 27 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
33.4 $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
36.8 $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
17.8 - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
13.6 - - $ 35.3 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
75.3 - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
21.2 - -0.04 % $ 2.62 B usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
158 - -23.04 % $ 26.6 M usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
136 - - $ 69.7 B britainBritain
Guardion Health Sciences Guardion Health Sciences
GHSI
62.6 - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
84.9 - - $ 109 M usaUSA
ImmunoGen ImmunoGen
IMGN
121 - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
114 - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
2.26 K - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
740 - - $ 591 K irlandaIrlanda
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
260 - -2.99 % $ 2.47 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
115 - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
0.653 - - $ 546 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
96.4 - - $ 35.4 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
31.4 - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
18.3 - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
18.4 - - $ 127 M usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
211 $ 84.95 0.13 % $ 7.99 B usaUSA
Gilead Sciences Gilead Sciences
GILD
57.8 $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
2.46 $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
56.5 - - $ 2.02 B usaUSA
Orgenesis Orgenesis
ORGS
22.6 - -33.86 % $ 61.2 M usaUSA